J&J re­ports lat­est da­ta on Balver­sa-based ‘pret­zel’ ther­a­py for blad­der can­cer

Blad­der can­cer pa­tients with a com­mon mu­ta­tion saw promis­ing ear­ly re­sults af­ter re­ceiv­ing a John­son & John­son tar­get­ed ther­a­py that ad­min­is­ters the drug sold as …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER